Timefolio Kbio Active ETF (KRX:463050)

Assets	n/a
Expense Ratio	n/a
PE Ratio	35.52
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-29.45%

Volume	239,746
Open	11,085
Previous Close	11,080
Day's Range	11,000 - 11,275
52-Week Low	10,450
52-Week High	21,970
Beta	0.64
Holdings	10
Inception Date	Aug 17, 2023

About 463050

463050.KQ was created on 2023-08-17 by Timefolio . The fund's investment portfolio concentrates primarily on health care equity.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 463050
• Provider: Timefolio

Performance

463050 had a total return of -29.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.38%.

Top Holdings

62.35% of assets

Name	Symbol	Weight
Celltrion, Inc.	068270	9.55%
OliX Pharmaceuticals, Inc	226950	9.08%
ALTEOGEN Inc.	196170	8.30%
Hanmi Pharm. Co., Ltd.	128940	6.35%
Hanall Biopharma Co., Ltd.	009420	5.96%
LigaChem Biosciences Inc.	141080	4.88%
Voronoi, Inc.	310210	4.64%
Samsung Biologics Co.,Ltd.	207940	4.59%
HanmiPharm Future Oct 26	12894=V6.KQ	4.54%
Celltrion Pharm, Inc.	068760	4.45%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error